Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.
Summary
- On June 25, 2024, Charles D. Baker, a director of UnitedHealth Group, acquired 2 shares of common stock.
- The acquisition was a result of dividend equivalents paid on vested deferred stock units.
- The price per share was $0.
- Following the transaction, Baker directly owns 292 shares of UnitedHealth Group common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard transaction (dividend equivalent). It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in trading activities by corporate insiders. This filing indicates routine compensation in the form of dividend equivalents.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares related to dividend equivalents.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of transaction: Acquisition of common stock. |
| 06/27/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.